IP Library Granted Patent US 6,855,492
Granted Patent B2
US 6,855,492 · App. 10/211,025 · Granted Feb 15, 2005

Use of microparticles combined with submicron oil-in-water emulsions

Assignee: Chiron Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,855,492
App. No.
10/211,025
Granted
Feb 15, 2005
Kind
B2
Abstract

Compositions are provided which include biodegradable microparticles with entrapped or adsorbed antigens, in combination with submicron oil-in-water emulsions. Also provided are methods of immunization which comprise administering to a vertebrate subject (a) a submicron oil-in-water emulsion, and (b) a therapeutically effective amount of a selected antigen entrapped in a microparticle.

Claims (15)

1. A method of inducing an immune response which comprises administering to a vertebrate subject (a) a submicron oil-in-water emulsion immunological adjuvant, and (b) a therapeutically effective amount of a selected antigen entrapped in, or adsorbed to, a biodegradable microparticle, wherein the submicron oil-in-water emulsion comprises 1% to 12% by volume of a non-toxic metabolizable oil and 0.02% to 2.5% (w/v) of emulsifying agent.

2. The method of claim 1 , wherein the microparticle is formed from a poly(α-hydroxy acid) selected from the group consisting of poly(L-lactide), poly(D,L-Iactide) and poly(D,L-lactide-co-glycolide).

3. The method of claim 2 , wherein the microparticle is formed from poly(D,L-lactide-co-glycolide.

4. The method of claim 1 , wherein the submicron oil-in-water emulsion comprises 4-5% w/v squalene, 0.25-0.5% w/v polyoxyethylene sorbitan monooleate, and 0.5% w/v sorbitan trioleate, and optionally, N-acetylmuramyl-L-alanyl-D-isogluatminyl-L-alanine-2-(1′-2′-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy)-ethylamine.

5. The method of claim 1 , wherein the selected antigen is a viral antigen.

6. The method of claim 5 , wherein the selected antigen is gp 120.

7. The method of claim 5 , wherein the selected antigen is p24gag.

8. The method of claim 5 , wherein the selected antigen is hepatitis C virus E2.

9. The method of claim 1 , wherein the selected antigen is entrapped in the microp article.

10. The method of claim 1 , wherein the selected antigen is adsorbed to the microparticle.

11. The method of claim 1 , wherein the submicron oil-in-water emulsion is administered prior to the microparticle.

12. The method of claim 1 , wherein the submicron oil-in-water emulsion is administered subsequent to the microparticle.

13. The method of claim 1 , wherein the submicron oil-in-water emulsion is administered substantially concurrently with the microparticle.

14. The method of claim 1 , wherein the submicron oil-in-water emulsion further comprises N-acetylmuramyl-L-alanyl-D-isogluatminyl-L-alanine-2-(1′-2′-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy)-ethylamine.

15. the method of claim 4 , wherein the submicron oil-in-water emulsion further comprises N-acetylmuramyl-L-alanyl-D-isogluatminyl-L-alanine-2-(1′-2′-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy)-ethylamine.

Assignments (1)
CHANGE OF NAME Recorded Jun 23, 2009
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 022856/0672 →
Continuity (5)
Continuation 0993546600 · Aug 20, 2001
Continuation 0956441600 · May 2, 2000
Division 0901573600 · Jan 29, 1998
Provisional Application 6006972400 · Dec 16, 1997
Related Publication 20030082213A1 · May 1, 2003